Manipal Health collects Rs 4,167 cr from anchor investors; IPO opens for public subscription
NiveshIQ
NSE: MEDANTA · Healthcare
Global Health Ltd.
₹1,432.90▲ ₹31.60 (+2.26%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on MEDANTA. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Global Health Ltd.
Global Health Limited, a leading Indian healthcare services provider, operates through its subsidiaries, offering a wide range of medical treatments across various specialties. The company's key revenue drivers include its hospitals, which generate significant revenue from patient admissions and treatments. Recent developments include management meetings with investors and analysts, highlighting the company's focus on growth and expansion. Global Health Limited competes with other major healthcare players in India, including Manipal Health Enterprises, which has recently gone public. The company's growth outlook is positive, driven by increasing demand for healthcare services in India and its expanding network of hospitals and services. With a strong presence in the Indian healthcare marke
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹3,269 Cr +133.30% | ₹3,692 Cr +12.90% | ₹4,410 Cr +19.50% |
| EBITDA Margin | 24.23% | 23.75% | 23.08% |
| Net Profit | ₹478.00 Cr +162.60% | ₹481.00 Cr +0.60% | ₹554.07 Cr +15.20% |
| EPS | ₹17.81 | ₹17.93 | ₹20.71 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Manipal Health Enterprises IPO Day 1: Issue booked 3% so far. Check GMP, key dates, review. Apply or not?
Manipal Health Enterprises Ltd IPO
🔒
+ 3 more stories about Global Health Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹1, 159 Cr, PAT ₹142 Cr, EPS ₹5.36, EBITDA margin 24.2%. Growth context: revenue YoY +24.5%, PAT YoY +40.2%, revenue QoQ +3.4%, PAT QoQ +49.1%. Street verdict: inline, revenue surprise +0.9%, PAT surprise +1.8%.
Recent corporate activity highlights new capacity addition and capex deployment and geographic expansion and internation...
FY26 (last completed FY): revenue ₹4, 410 Cr, PAT ₹554 Cr, EBITDA margin 23.1%, EPS ₹20.71. Year-on-year: revenue YoY +1...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for MEDANTA
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track MEDANTA alongside your other holdings
Unlock full MEDANTA research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Global Health Ltd.?
NiveshIQ detects active intelligence signals for Global Health Ltd. (MEDANTA) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Global Health Ltd.?
Global Health Ltd. operates in the Healthcare sector with a market capitalisation of ₹3,424,836.6L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.